Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates.
Capone S, Zampaglione I, Vitelli A, Pezzanera M, Kierstead L, Burns J, Ruggeri L, Arcuri M, Cappelletti M, Meola A, Ercole BB, Tafi R, Santini C, Luzzago A, Fu TM, Colloca S, Ciliberto G, Cortese R, Nicosia A, Fattori E, Folgori A. Capone S, et al. Among authors: ercole bb. J Immunol. 2006 Nov 15;177(10):7462-71. doi: 10.4049/jimmunol.177.10.7462. J Immunol. 2006. PMID: 17082666
Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
Puntoriero G, Meola A, Lahm A, Zucchelli S, Ercole BB, Tafi R, Pezzanera M, Mondelli MU, Cortese R, Tramontano A, Galfre' G, Nicosia A. Puntoriero G, et al. Among authors: ercole bb. EMBO J. 1998 Jul 1;17(13):3521-33. doi: 10.1093/emboj/17.13.3521. EMBO J. 1998. PMID: 9649423 Free PMC article.
Mimotopes of the hyper variable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes.
Roccasecca R, Folgori A, Ercole BB, Puntoriero G, Lahm A, Zucchelli S, Tafi R, Pezzanera M, Galfre G, Tramontano A, Mondelli MU, Pessi A, Nicosia A, Cortese R, Meola A. Roccasecca R, et al. Among authors: ercole bb. Mol Immunol. 2001 Dec;38(6):485-92. doi: 10.1016/s0161-5890(01)00084-0. Mol Immunol. 2001. PMID: 11741698
Induction of cross-reactive humoral immune response by immunization with mimotopes of the hypervariable region 1 of the hepatitis C virus.
Roccasecca R, Folgori A, Ercole BB, Puntoriero G, Lahm A, Zucchelli S, Tafi R, Pezzanera M, Galfre G, Tramontano A, Mondelli MU, Pessi A, Nicosia A, Cortese R, Meola A. Roccasecca R, et al. Among authors: ercole bb. Int Rev Immunol. 2001;20(2):289-300. doi: 10.3109/08830180109043040. Int Rev Immunol. 2001. PMID: 11878771
Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.
Roccasecca R, Ansuini H, Vitelli A, Meola A, Scarselli E, Acali S, Pezzanera M, Ercole BB, McKeating J, Yagnik A, Lahm A, Tramontano A, Cortese R, Nicosia A. Roccasecca R, et al. Among authors: ercole bb. J Virol. 2003 Feb;77(3):1856-67. doi: 10.1128/jvi.77.3.1856-1867.2003. J Virol. 2003. PMID: 12525620 Free PMC article.
A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques.
Capone S, Meola A, Ercole BB, Vitelli A, Pezzanera M, Ruggeri L, Davies ME, Tafi R, Santini C, Luzzago A, Fu TM, Bett A, Colloca S, Cortese R, Nicosia A, Folgori A. Capone S, et al. Among authors: ercole bb. J Virol. 2006 Feb;80(4):1688-99. doi: 10.1128/JVI.80.4.1688-1699.2006. J Virol. 2006. PMID: 16439526 Free PMC article.
A model for the hepatitis C virus envelope glycoprotein E2.
Yagnik AT, Lahm A, Meola A, Roccasecca RM, Ercole BB, Nicosia A, Tramontano A. Yagnik AT, et al. Among authors: ercole bb. Proteins. 2000 Aug 15;40(3):355-66. doi: 10.1002/1097-0134(20000815)40:3<355::aid-prot20>3.0.co;2-k. Proteins. 2000. PMID: 10861927
Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming-boosting with novel adenoviral vectors based on different serotypes.
Fattori E, Zampaglione I, Arcuri M, Meola A, Ercole BB, Cirillo A, Folgori A, Bett A, Cappelletti M, Sporeno E, Cortese R, Nicosia A, Colloca S. Fattori E, et al. Among authors: ercole bb. Gene Ther. 2006 Jul;13(14):1088-96. doi: 10.1038/sj.gt.3302754. Epub 2006 Mar 23. Gene Ther. 2006. PMID: 16554842
13 results